خدمات البيع بالتجزئة أو البيع بالجملة بالفئة 35 للمستحضرات الصيدلانية;
News around "BEIGENE" trademark
News sentiment analysis powered by sentiment-insight.com
2023-11-21
positive
BeiGene to buy global rights to Ensem's experimental...
BeiGene will work with Ensem Therapeutics to bring the therapy to trials. Ensem will receive an upfront payment and will be eligible for additional payments totaling up to $1.33 billion.
2023-11-21
positive
UPDATE 1-BeiGene to buy global rights to Ensem's experimental cancer therapy
BeiGene said it would buy the global license for a cancer therapy from Ensem Therapeutics. The Hong Kong-listed company will work with Ensem to bring the therapy to trials.
2023-03-22
positive
BeiGene Expects To Finish Construction At $700 Million New Jersey Site In 2024
BeiGene, a global biotech company with offices in China, Switzerland and Cambridge, Mass., expects to finish construction of a $700 million investment site in New Jersey next year. The facility will have approximately 400,000 square feet of commercial-stage biologic pharmaceutical manufacturing space with the ability to add 600,000 more over time.
2023-03-11
negative
BeiGene's Elliott Wave Correction Is Far From Over
BeiGene (NASDAQ:BGNE) develops and commercializes oncology medicines globally. Like most other biotechnology companies, BGNE is not profitable. The stock’s value derives mainly from the market's...
2023-01-23
positive
Following Alzheimer’s drug approval, analysts dish on what they expect from Biogen in 2023
FDA rejects accelerated approval for Eli Lilly's Alzheimer's drug donanemab. BeiGene's Brukinsa wins CLL approval after topping Imbruvica in head-to-head trial. Atomwise lays off 30% of staffers amid'strategic shift'
2023-01-01
positive
Saudi Arabia Concrete Admixture Market Report 2022: Prospects, Trends Analysis, Market Size and Forecasts up to 2028 - ResearchAndMarkets.com
5G Chipset Global Market Report 2022: Industry to Reach $92.05 Billion by 2030 with 21.8% Annual Growth - ResearchAndMarkets.com. The global lighting as a service market size reached US$ 408.8 Million in 2021. Looking forward, the market is set to reach US$ 4,529.44 Million by 2027, exhibiting a CAGR of 49.31% during 2021-2027. ING completes share buyback programme; remaining €297 million cash to be paid to shareholders in January. BeiGene Announces Acceptance of 12th Regulatory Submission in China for PD-1 Inhibitor Tislelizumab.
Are you owner?
Would you like more about our services?We have various offers for you!
Are you IP company?
Would you like more about our services? We have different offers
for you
Sign Up
